212 related articles for article (PubMed ID: 32919399)
1. Behavioral and neurobiological effects of GnRH agonist treatment in mice-potential implications for puberty suppression in transgender individuals.
Anacker C; Sydnor E; Chen BK; LaGamma CC; McGowan JC; Mastrodonato A; Hunsberger HC; Shores R; Dixon RS; McEwen BS; Byne W; Meyer-Bahlburg HFL; Bockting W; Ehrhardt AA; Denny CA
Neuropsychopharmacology; 2021 Apr; 46(5):882-890. PubMed ID: 32919399
[TBL] [Abstract][Full Text] [Related]
2. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
[TBL] [Abstract][Full Text] [Related]
3. Children and adolescents in the Amsterdam Cohort of Gender Dysphoria: trends in diagnostic- and treatment trajectories during the first 20 years of the Dutch Protocol.
van der Loos MATC; Klink DT; Hannema SE; Bruinsma S; Steensma TD; Kreukels BPC; Cohen-Kettenis PT; de Vries ALC; den Heijer M; Wiepjes CM
J Sex Med; 2023 Feb; 20(3):398-409. PubMed ID: 36763938
[TBL] [Abstract][Full Text] [Related]
4. The peripubertal gender-dysphoric child: puberty suppression and treatment paradigms.
Olson J; Garofalo R
Pediatr Ann; 2014 Jun; 43(6):e132-7. PubMed ID: 24972421
[TBL] [Abstract][Full Text] [Related]
5. Puberty Assessment and Consideration of Gonadotropin-Releasing Hormone Agonists in Transgender and Gender-Diverse Youth.
Lee JY
Pediatr Ann; 2023 Dec; 52(12):e462-e466. PubMed ID: 38049185
[TBL] [Abstract][Full Text] [Related]
6. Continuation of gender-affirming hormones in transgender people starting puberty suppression in adolescence: a cohort study in the Netherlands.
van der Loos MATC; Hannema SE; Klink DT; den Heijer M; Wiepjes CM
Lancet Child Adolesc Health; 2022 Dec; 6(12):869-875. PubMed ID: 36273487
[TBL] [Abstract][Full Text] [Related]
7. Growth in Transgender/Gender-Diverse Youth in the First Year of Treatment With Gonadotropin-Releasing Hormone Agonists.
Schulmeister C; Millington K; Kaufman M; Finlayson C; Kennedy JO; Garofalo R; Chan YM; Rosenthal SM
J Adolesc Health; 2022 Jan; 70(1):108-113. PubMed ID: 34315674
[TBL] [Abstract][Full Text] [Related]
8. [Puberty Suppression for Adolescents with Gender Dysphoria A Japanese Perspective].
Matsumoto Y
Seishin Shinkeigaku Zasshi; 2017; 119(1):42-51. PubMed ID: 30629867
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review: Puberty suppression with GnRH analogues in adolescents with gender incongruity.
Ramos GGF; Mengai ACS; Daltro CAT; Cutrim PT; Zlotnik E; Beck APA
J Endocrinol Invest; 2021 Jun; 44(6):1151-1158. PubMed ID: 33111215
[TBL] [Abstract][Full Text] [Related]
10. Transition memories: experiences of trans adult women with hormone therapy and their beliefs on the usage of hormone blockers to suppress puberty.
Giovanardi G; Morales P; Mirabella M; Fortunato A; Chianura L; Speranza AM; Lingiardi V
J Endocrinol Invest; 2019 Oct; 42(10):1231-1240. PubMed ID: 30953318
[TBL] [Abstract][Full Text] [Related]
11. Transgender medicine - puberty suppression.
Panagiotakopoulos L
Rev Endocr Metab Disord; 2018 Sep; 19(3):221-225. PubMed ID: 30112593
[TBL] [Abstract][Full Text] [Related]
12. Perceptions of Sex, Gender, and Puberty Suppression: A Qualitative Analysis of Transgender Youth.
Vrouenraets LJ; Fredriks AM; Hannema SE; Cohen-Kettenis PT; de Vries MC
Arch Sex Behav; 2016 Oct; 45(7):1697-703. PubMed ID: 27251640
[TBL] [Abstract][Full Text] [Related]
13. Pubertal Suppression, Bone Mass, and Body Composition in Youth With Gender Dysphoria.
Navabi B; Tang K; Khatchadourian K; Lawson ML
Pediatrics; 2021 Oct; 148(4):. PubMed ID: 34497118
[TBL] [Abstract][Full Text] [Related]
14. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study.
de Vries AL; Steensma TD; Doreleijers TA; Cohen-Kettenis PT
J Sex Med; 2011 Aug; 8(8):2276-83. PubMed ID: 20646177
[TBL] [Abstract][Full Text] [Related]
15. Chronic periadolescent leuprolide exposure affects the development of reproductive physiology and behavior of female and male rats differently, but both mature after treatment termination.
Guarraci FA; Avendano L; Kelly M; Estoesta C; Sencherey B; Valdivia HS; Gale A; Yepez L; Belfield JB; Carter KM; Williams N; Gore AC
Biol Sex Differ; 2023 Jan; 14(1):1. PubMed ID: 36609535
[TBL] [Abstract][Full Text] [Related]
16. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline.
Hembree WC; Cohen-Kettenis PT; Gooren L; Hannema SE; Meyer WJ; Murad MH; Rosenthal SM; Safer JD; Tangpricha V; T'Sjoen GG
J Clin Endocrinol Metab; 2017 Nov; 102(11):3869-3903. PubMed ID: 28945902
[TBL] [Abstract][Full Text] [Related]
17. [Transgender and Gender Dysphoria: Viewpoints on Clinical Care and Psychological Stress].
Hsu CY
Hu Li Za Zhi; 2023 Feb; 70(1):17-22. PubMed ID: 36647306
[TBL] [Abstract][Full Text] [Related]
18. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
[TBL] [Abstract][Full Text] [Related]
19. Gender incongruence and gender dysphoria in childhood and adolescence-current insights in diagnostics, management, and follow-up.
Claahsen-van der Grinten H; Verhaak C; Steensma T; Middelberg T; Roeffen J; Klink D
Eur J Pediatr; 2021 May; 180(5):1349-1357. PubMed ID: 33337526
[TBL] [Abstract][Full Text] [Related]
20. Gonadal suppressive and cross-sex hormone therapy for gender dysphoria in adolescents and adults.
Smith KP; Madison CM; Milne NM
Pharmacotherapy; 2014 Dec; 34(12):1282-97. PubMed ID: 25220381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
